LRP4 and myasthenia gravis: MG patients can generate autoantibodies against postsynaptic neuromuscular proteins and epitopes such as acetylcholine receptor (AChR), muscle-specific tyrosine kinase (MuSK), and lipoprotein receptor-related protein-4 (LRP4) to attack the body's tissues [4–6].